Cargando…

Comparing Copper Serum Level and Cognitive Functioning in Patients With Schizophrenia and Healthy Controls

INTRODUCTION: The altered serum profiles of several trace elements have been reported in Schizophrenia (SCZ). This study was designed to elucidate whether the serum levels of Copper (Cu) and Magnesium (Mg), the two essential trace elements which contribute to neurotransmitter transmission, are alter...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazhari, Shahrzad, Arjmand, Shokouh, Eslami Shahrbabaki, Mahin, Karimi Ghoughari, Elham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Neuroscience Society 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878054/
https://www.ncbi.nlm.nih.gov/pubmed/33643558
http://dx.doi.org/10.32598/bcn.9.10.11.5.2116.1
_version_ 1783650279698202624
author Mazhari, Shahrzad
Arjmand, Shokouh
Eslami Shahrbabaki, Mahin
Karimi Ghoughari, Elham
author_facet Mazhari, Shahrzad
Arjmand, Shokouh
Eslami Shahrbabaki, Mahin
Karimi Ghoughari, Elham
author_sort Mazhari, Shahrzad
collection PubMed
description INTRODUCTION: The altered serum profiles of several trace elements have been reported in Schizophrenia (SCZ). This study was designed to elucidate whether the serum levels of Copper (Cu) and Magnesium (Mg), the two essential trace elements which contribute to neurotransmitter transmission, are altered in patients with SCZ. We also investigated whether there is an interrelation between cognitive functioning and the serum levels of Cu and Mg. METHODS: Sixty patients with SCZ and 30 healthy controls participated in this study. The patient group was divided into the following: i) early patients (n=35, ≤5 years of illness initiation), and ii) chronic patients (n=25, ≥5 years of illness duration). The serum levels of Cu and Mg were measured by atomic absorption spectroscopy and ion-selective electrode potentiometry, respectively. To assess cognitive abilities, a Persian adaptation of the Brief Assessment of Cognition in Schizophrenia (BACS) was administered. RESULTS: The present research results revealed significantly higher Cu serum levels in both patient groups [early patients (M=94.6), chronic patients (M=97.5)], compared to the controls (M=71.0) (P<0.001); however, no significant difference was observed among the study groups for Mg [patients with the recent onset (M=2.0), chronic patients (M=2.0), and controls (M=1.9)] P=0.1. While the serum Cu profile of healthy individuals revealed a negative correlation with working memory (r=−0.42, P=0.02), and executive functioning (r=−0.40, P=0.03), no significant correlation was observed between Cu serum levels of patients and BACS cognitive domains. CONCLUSION: findings suggested that the high Cu serum concentration might impact the cognitive decline in healthy individuals; however, no significant correlation was observed in the Patients; i.e. most likely because cognition is severely impaired in SCZ. Additional studies examining trace elements in drug-naïve patients with SCZ are required.
format Online
Article
Text
id pubmed-7878054
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Iranian Neuroscience Society
record_format MEDLINE/PubMed
spelling pubmed-78780542021-02-27 Comparing Copper Serum Level and Cognitive Functioning in Patients With Schizophrenia and Healthy Controls Mazhari, Shahrzad Arjmand, Shokouh Eslami Shahrbabaki, Mahin Karimi Ghoughari, Elham Basic Clin Neurosci Research Paper INTRODUCTION: The altered serum profiles of several trace elements have been reported in Schizophrenia (SCZ). This study was designed to elucidate whether the serum levels of Copper (Cu) and Magnesium (Mg), the two essential trace elements which contribute to neurotransmitter transmission, are altered in patients with SCZ. We also investigated whether there is an interrelation between cognitive functioning and the serum levels of Cu and Mg. METHODS: Sixty patients with SCZ and 30 healthy controls participated in this study. The patient group was divided into the following: i) early patients (n=35, ≤5 years of illness initiation), and ii) chronic patients (n=25, ≥5 years of illness duration). The serum levels of Cu and Mg were measured by atomic absorption spectroscopy and ion-selective electrode potentiometry, respectively. To assess cognitive abilities, a Persian adaptation of the Brief Assessment of Cognition in Schizophrenia (BACS) was administered. RESULTS: The present research results revealed significantly higher Cu serum levels in both patient groups [early patients (M=94.6), chronic patients (M=97.5)], compared to the controls (M=71.0) (P<0.001); however, no significant difference was observed among the study groups for Mg [patients with the recent onset (M=2.0), chronic patients (M=2.0), and controls (M=1.9)] P=0.1. While the serum Cu profile of healthy individuals revealed a negative correlation with working memory (r=−0.42, P=0.02), and executive functioning (r=−0.40, P=0.03), no significant correlation was observed between Cu serum levels of patients and BACS cognitive domains. CONCLUSION: findings suggested that the high Cu serum concentration might impact the cognitive decline in healthy individuals; however, no significant correlation was observed in the Patients; i.e. most likely because cognition is severely impaired in SCZ. Additional studies examining trace elements in drug-naïve patients with SCZ are required. Iranian Neuroscience Society 2020 2020-09-01 /pmc/articles/PMC7878054/ /pubmed/33643558 http://dx.doi.org/10.32598/bcn.9.10.11.5.2116.1 Text en Copyright© 2020 Iranian Neuroscience Society This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Research Paper
Mazhari, Shahrzad
Arjmand, Shokouh
Eslami Shahrbabaki, Mahin
Karimi Ghoughari, Elham
Comparing Copper Serum Level and Cognitive Functioning in Patients With Schizophrenia and Healthy Controls
title Comparing Copper Serum Level and Cognitive Functioning in Patients With Schizophrenia and Healthy Controls
title_full Comparing Copper Serum Level and Cognitive Functioning in Patients With Schizophrenia and Healthy Controls
title_fullStr Comparing Copper Serum Level and Cognitive Functioning in Patients With Schizophrenia and Healthy Controls
title_full_unstemmed Comparing Copper Serum Level and Cognitive Functioning in Patients With Schizophrenia and Healthy Controls
title_short Comparing Copper Serum Level and Cognitive Functioning in Patients With Schizophrenia and Healthy Controls
title_sort comparing copper serum level and cognitive functioning in patients with schizophrenia and healthy controls
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878054/
https://www.ncbi.nlm.nih.gov/pubmed/33643558
http://dx.doi.org/10.32598/bcn.9.10.11.5.2116.1
work_keys_str_mv AT mazharishahrzad comparingcopperserumlevelandcognitivefunctioninginpatientswithschizophreniaandhealthycontrols
AT arjmandshokouh comparingcopperserumlevelandcognitivefunctioninginpatientswithschizophreniaandhealthycontrols
AT eslamishahrbabakimahin comparingcopperserumlevelandcognitivefunctioninginpatientswithschizophreniaandhealthycontrols
AT karimighougharielham comparingcopperserumlevelandcognitivefunctioninginpatientswithschizophreniaandhealthycontrols